PSAP and prostate carcinoma: To comprehensively assess the prevalence of PSAP expression in many human tumor types, and to estimate the putative diagnostic value of PSAP IHC in prostate cancer, tissue microarrays (TMAs) made from more than 30,000 tumor samples from 132 different tumor types and subtypes, as well as 76 normal tissue categories, were studied.